Altered glutamyl-aminopeptidase activity and expression in renal neoplasms

Background: Advances in the knowledge of renal neoplasms have demonstrated the implication of several proteases in their genesis, growth and dissemination. Glutamyl-aminopeptidase (GAP) (EC. 3.4.11.7) is a zinc metallopeptidase with angiotensinase activity highly expressed in kidney tissues and its...

ver descrição completa

Detalhes bibliográficos
Autores: Blanco Criado, Lorena, Sanz Echevarría, María Begoña, Pérez Urzelai, Itxaro, Sánchez Fernández, Clara Eugenia, Candenas, Luz, Pinto, Francisco M., Gil Goicouría, Francisco Javier, Casis Sáenz, Luis, López Fernández de Villaverde, José Ignacio, Larrinaga Embeita, Gorka
Formato: artículo
Fecha de publicación:2014
País:España
Recursos:Universidad del País Vasco
Repositorio:Addi. Archivo Digital para la Docencia y la Investigación
OAI Identifier:oai:addi.ehu.eus:10810/16788
Acesso em linha:http://hdl.handle.net/10810/16788
Access Level:acceso abierto
Palavra-chave:glutamyl-aminopeptidase
aminopeptidase A
angiotensinase
angiotensin
clear cell renal cell carcinoma
renal neoplasm
renin-angiotension system
real-time PCR
cell carcinoma
tachykinin receptors
cancer
kidney
ectopeptidases
hypothesis
IV/CD26
tissue
GENETICS AND HEREDITY
ONCOLOGY
Descrição
Resumo:Background: Advances in the knowledge of renal neoplasms have demonstrated the implication of several proteases in their genesis, growth and dissemination. Glutamyl-aminopeptidase (GAP) (EC. 3.4.11.7) is a zinc metallopeptidase with angiotensinase activity highly expressed in kidney tissues and its expression and activity have been associated wtih tumour development. Methods: In this prospective study, GAP spectrofluorometric activity and immunohistochemical expression were analysed in clear-cell (CCRCC), papillary (PRCC) and chromophobe (ChRCC) renal cell carcinomas, and in renal oncocytoma (RO). Data obtained in tumour tissue were compared with those from the surrounding uninvolved kidney tissue. In CCRCC, classic pathological parameters such as grade, stage and tumour size were stratified following GAP data and analyzed for 5-year survival. Results: GAP activity in both the membrane-bound and soluble fractions was sharply decreased and its immunohistochemical expression showed mild staining in the four histological types of renal tumours. Soluble and membrane-bound GAP activities correlated with tumour grade and size in CCRCCs. Conclusions: This study suggests a role for GAP in the neoplastic development of renal tumours and provides additional data for considering the activity and expression of this enzyme of interest in the diagnosis and prognosis of renal neoplasms.